Categories: News

A New Chapter of Bold Leadership and Unstoppable Growth

LEHI, Utah, July 24, 2025 /PRNewswire/ — Amare Global, The Mental Wellness Company™, is pleased to announce a powerful new chapter; effective immediately, David Chung, Owner and Chairman of Amare Global, will assume the role of Chief Executive Officer. With an unmatched passion for Amare’s mission and a relentless drive to see every brand partner succeed, Chung is stepping into this role to lead Brand Partners into the most exciting and expansive era in Amare history.

- Advertisement -

“We are grateful for Asma Ishaq’s leadership and wish her continued success,” said Chung of Amare’s former CEO.

- Advertisement -

Amare Global’s mission is to lead the global mental wellness movement under Chung’s visionary leadership. Chung relays, “Amare is shifting into high gear. This is a moment of alignment, acceleration, and absolute belief in our purpose, our people, and our potential. Brand Partners, now is your time. This shift will create greater stability as we invest deeper, dream bigger, and execute bolder than ever before. This is more than a leadership transition—it’s a leadership elevation.”

- Advertisement -

A serial entrepreneur, Chung has an extensive track record of building brands, developing cutting-edge innovation, and leading high-performance teams. Chung will focus on expanding innovation, driving global growth, and deepening Amare’s impact as an industry leader.

- Advertisement -

About Amare Global
Amare Global® is recognized as a category leader in the mental wellness movement, offering innovative solutions informed by the powerful relationship of the gut microbiome and the gut-brain axis (GBX). Dedicated to quality and backed by award-winning US patented formulations, Amare Global is committed to delivering transformative solutions that foster love—Amare means “to love” in Latin.

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/a-new-chapter-of-bold-leadership-and-unstoppable-growth-302512495.html

- Advertisement -

Recent Posts

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

The new data demonstrates the potential to improve control of acute infection, latency, and viral…

3 hours ago

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

July 12, 2026 06:28 ET  | Source: Hemab Therapeutics, Inc. HMB-002 clinical data demonstrate proof…

3 hours ago

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2026

FORMER ELITE SOCCER PLAYERS SHOWEVIDENCE OF BRAIN HEALTH CHANGES IN MID-LIFEKey TakeawaysNew research provides insights…

3 hours ago

GAC Group to Celebrate 30 Million Global Users on July 16

GUANGZHOU, China, July 12, 2026 /PRNewswire/ -- From the roll-off of its first vehicle to…

6 hours ago

What Separates Commercial Money Counters From Consumer Models?

MIAMI, FL, July 11, 2026 (GLOBE NEWSWIRE) -- To a first-time buyer, a consumer money…

16 hours ago